Analyst Ratings for Novo Nordisk (NVO) [Neutrals]
NVO Rating Summary
NVO Price Target Summary
- Highest: $163.00 (BMO Capital)
- Lowest: $115.00 (TD Cowen)
- Average: $140.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$140.40 (+12.1%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$140.40 (+12.1%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2021 | Deutsche Bank | Emmanuel Papadakis | Downgrade | Hold (Buy) |
N/A (N/A) |
117.08 (125.26) |
6.99% | Details |
| 5/4/2020 | TD Cowen » Updated 12/4/2023 |
Steven Scala | New Coverage | Hold (N/A) |
115.00 (105.00) |
63.33 (125.26) |
97.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
